Ga-PSMA PET/CT for monitoring response to Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer.
European journal of nuclear medicine and molecular imaging
View this publicationEuropean journal of nuclear medicine and molecular imaging
View this publicationScientific reports
View this publicationHepatology communications
View this publicationScientific reports
View this publicationBMJ (Clinical research ed.)
View this publicationInternational journal of rheumatic diseases
View this publicationThe Journal of biological chemistry
View this publicationCardiovascular diabetology
View this publicationSeminars in liver disease
View this publicationTranslational psychiatry
View this publication